7,874
Views
137
CrossRef citations to date
0
Altmetric
Review

The Impact of Blood Shear Rate On Arterial Thrombus Formation

, &
Article: FSO30 | Published online: 02 Jul 2015

References

  • Baumgartner HR . The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc. Res.5, 167–179 (1973).
  • Weiss HJ , TurittoVT, BaumgartnerHR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. 1. Shear-dependant decrease of adhesion in von Willebrand's ddisease and the Bernard-Soulier syndrome. J. Lab. Clin. Med.92, 750–764 (1978).
  • Baumgartner HR , SakariassenKS. Factors controlling thrombus formation on arterial lesions. Ann. NY Acad. Sci.454, 162–177 (1985).
  • Sakariassen KS , HansonSR, CadroyY. Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy. Thromb. Res.104, 149–174 (2001).
  • Sakariassen KS , TurittoVT, Baumgartner. Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood. J. Thromb. Haemost.2, 1681–1690 (2004).
  • Roux SP , SakariassenKS, TurittoVTet al. Effect of aspirin and epinephrine on experimentally-induced thrombogenesis in dogs: a parallelism between in vivo and ex vivo thrombosis models. Arterioscler. Thromb.11, 1182–1191 (1991).
  • Strony J , BeaudinA, BrandsDet al. Analysis of shear stress and hemodynamic factors in a model of artery stenosis and thrombosis. Am. J. Physiol.265, H1787–H1796 (1993).
  • Hutchison KJ , KarpinskiE. In vivo demonstration of flow recirculation and turbulence downstream of graded stenoses in canine arteries. J. Biomech.18(4), 285–296 (1985).
  • Aarts PA , van den BroekSA, PrinsGWet al. Blood platelets are concentrated near the wall and red blood cells in the center in flowing blood. Arteriosclerosis8(6), 819–824 (1988).
  • Turitto VT . Blood viscosity, mass transport, and thrombogenesis. In: Progress In Hemostasis And Thrombosis. SpaetTM ( Ed.). Grune & Stratton, NY, USA, 5, 139–174 (1981).
  • Goldsmith HL , TurittoVT. Rheological aspects of thrombosis and hemostasis: basic principles and applications. Thromb. Haemost.55, 415–435 (1986).
  • Sakariassen KS , FressinaudE, GirmaJPet al. Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen. Ann. NY Acad. Sci.516, 52–65 (1987).
  • Orvim U , BarstadRM, VlasukGPet al. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of human shear dependent thrombus formation. Arterioscler. Thromb. Vasc. Biol.15, 2188–2194 (1995).
  • Sakariassen KS , AartsPAMM, de GrootPGet al. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J. Lab. Clin. Med.102, 522–535 (1983).
  • Sakariassen KS , JossR, MuggliRet al. Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis10(2), 276–284 (1990).
  • Orvim U , RoaldHE, StephensRWet al. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler. Thromb.14(12), 1976–1983 (1994).
  • Aznar-Salatti J , AntonP, NemersonYet al. Modulation of procoagulant activity of extracellular endothlial matrix by anti-tissue factor and the synthetic peptide arg-gly-asp-val. Experiments with flowing non-antigoaulated blood. Blood Coag. Fibrinol.4(6), 881–890 (1993).
  • Diquelou A , DupouyD, GaspinDet al. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions. Thromb. Haemost.74(2), 778–783 (1995).
  • Sakariassen KS . Thrombus formation on apex of arterial stenoses: the need for a fluid high shear diagnosis device. Future Cardiol.3(2), 193–201 (2007).
  • Sakariassen KS , KuhnH, MuggliRet al. Growth and stability of thrombi in flowing citrated blood: assessment of platelet-surface interactions with computer-assisted morphometry. Thromb. Haemost.60(33), 392–398 (1988).
  • Orvim U , BarstadM, StormorkenHet al. Immunological quantification of fibrin deposition in thrombi formed in flowing native blood. Brit. J. Haematol.95, 389–398 (1996).
  • Bossavy JP , SakariassenKS, BarretAet al. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis. Thromb Haemost.79, 162–168 (1998).
  • Barstad RM , RoaldHE, CuiYet al. A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. Arterioscler. Thromb.14(12), 1984–1991 (1994).
  • Baumgartner HR , SakariassenKS. Factors controlling thrombus formation on arterial lesions. Ann. NY Acad. Sci.454, 162–177 (1985).
  • Barstad RM , KierulfP, SakariassenKS. Collagen-induced thrombus formation at the apex of eccentric stenoses. A time-course study with non-anticoagulated blood. Thromb. Haemost.75(5), 685–692 (1996).
  • Weiss HJ , TurittoVT, BaumgartnerHR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib and storage granules. Blood67, 322–330 (1986).
  • Weiss HJ , TurittoVT, BaumgartnerHR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J. Clin. Invest.78, 1072–1082 (1986).
  • Fressinaud E , SakariassenKS, RothschildCet al. Shear-dependent impairment of thrombus growth on collagen in non-anticoagulated blood from patients with von Willebrand disease and Hemophilia A. Blood80, 988–994 (1992).
  • Barstad RM , OrvimU, HamersMJAGet al. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb. Haemost.75, 827–832 (1996).
  • Cadroy Y , SakariassenKS, CharletJPet al. Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood98, 1097–1103 (2001).
  • Barstad RM , StormorkenH, OrningLet al. Reduced thrombus formation in native blood of homozygous factor VII deficient patients at high arterial wall shear rate. Blood84, 3371–3377 (1994).
  • Sakariassen KS , BarstadRM. Mechanisms of thrombus formation at arterial plaques. Blood Coag. Fibrinol.4, 615–625 (1993).
  • Veen G , MeyerA, VerheugtFWet al. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the prevention of reocclusion in coronary thrombolysis. J. Am. Coll. Cardiol.22, 1755–1762 (1993).
  • Bossavy JP , ThalamasC, SagnardLet al. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin and ticlopidine alone on experimental arterial thrombogenesis in humans. Blood92, 1518–1525 (1998).
  • Roald HE , BarstadRM, KierulfPet al. Clopidogrel – a platelet inhibitor which inhibits thrombogenesis in human non-anticoagulated blood independently of the blood flow conditions. Thromb. Haemost.71, 665–672 (1994).
  • Roald HE , BarstadRM, EngenAet al. HN-1150 – a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions. Thromb. Haemost.71, 103–109 (1994).
  • Kirchhofer D , TschoppTB, SteinerBet al. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood86, 3815–3822 (1995).
  • Cadroy Y , BossavyJP, ThalamasCet al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation101, 2823–2828 (2000).
  • Cadroy Y , ThalamasC, SakariassenKSet al. Superior efficacy of clopidogrel plus acetylsalicyclic acid compared with extended-release dipyridamole plus acetylsalicyclic acid in preventing arterial thrombosis in healthy volunteers. Thromb. Res.116, 293–300 (2005).
  • Harker LA , KadatzRA. Mechanism action of dipyridamole. Thromb. Res.29(1), 39–46 (1983).
  • Terpening C . An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events. J. Am. Board Fam. Med.22(1), 51–56 (2009).
  • Halkes PH , van GijnJ, KapelleLJ, KoudstaalPJ, AlgraA. Aspirin plus dipyridamole versus aspirin alone after ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet367, 1665–1673 (2006).
  • Diquelou A , DupouyD, CariouRet al. A comparative study of the anticoagulant and antithrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis. Thromb. Haemost.74, 1286–1292 (1995).
  • Kirchhofer D , TschoppTB, BaumgartnerHR. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model. Arterioscler. Thromb. Vasc. Biol.15, 1098–1106 (1995).
  • Bossavy JP , SakariassenKS, ThalamasCet al. Antithrombotic efficacy of the vitamin K antagonist fluinidone in a human ex vivo model of arterial thrombosis. Effect of anticoagulation level and combination therapy with aspirin. Arterioscler. Thromb. Vasc. Biol.19, 2269–2275 (1999).
  • Bossavy JP , SakariassenKS, RubsamenKet al. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human model of arterial thrombosis. Arterioscler. Thromb. Vasc. Biol.19, 1348–1353 (1999).
  • Kirchhofer D , TschoppTB, HadvaryPet al. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. J. Clin. Invest.93, 2073–2083 (1994).
  • Orvim U , BarstadRM, OrningLet al. Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood. Arterioscler. Thromb. Vasc. Biol.17, 3049–3056 (1997).
  • Orning L , FischerPM, HuCKet al. A cyclic pentapeptide derived from the EGF-2 like domain of factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Thromb. Haemost.87, 13–21 (2002).
  • Lindahl AK , SandsetPM, Thune-WigerMet al. Tissue factor pathway inhibitor prevents fibrin deposition on procoagulant subendothelial matrix when exposed to flowing non-anticoagulated human blood. Blood Coag. Fibrinol.5, 755–760 (1994).
  • van Heerde WL , SakariassenKS, HemkerHCet al. Annexin V inhibits the procoagulant activity of TNF-stimulated endothelial cells under flow conditions. Arterioscler. Thromb.14, 824–830 (1994).
  • Barstad RM , HamersMJAG, StephensRWet al. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa dependent thrombus formation. Blood86, 212–218 (1995).
  • Sakariassen KS . Blood flow devices in medical research and clinical testing in humans: are we approaching personalized medicine?Future Cardiol.3(1), 71–90 (2007).
  • Zwaginga JJ , NashG, KingMRet al. Flow-based assays for global assessment of hemostasis. Part 1: biorheological considerations. J. Thromb. Haemost.4, 2486–2487 (2006).
  • Zwaginga JJ , SakariassenKS, NashGet al. Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future. J. Thromb. Haemost.4, 2716–2717 (2006).
  • Roest M , ReiningerA, ZwagingaJJet al. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J. Thromb. Haemost.9, 2322–2324 (2011).